Sajal Kumar Jha
Sajal Kumar Jha has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Roopa Karki
Department of Pharmaceutics & Pharmacology
2 shared publications- A. Geethalakshmi
Department of Pharmaceutics, The Oxford College of Pharmacy, #6/9, I. cross, Begur Road, Hongasandra, Bommanahalli, Hongasandra, Bangalore-560068, Karnataka, India
1 shared publication - Ashim Kumar Sen
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Waghodia, Vadodara-391760, Gujarat, India
1 shared publication B. Nikunj
1 shared publication- Babasahib Sajeev Kumar
Asian Institute of Medicine Science and Technology, Semeling , Bedong , Malaysia
1 shared publication D. P. Venkates
Acharya and B.M Reddy College of Pharmacy, Soladevanahalli, Bangalore KarnatakaIndia
1 shared publication
Latest Publications
- 9 September 2026
- Published by Bentham Science Publishers Ltd. in Current Functional Foods
- Vol. 04, 1-17
A Narrative Review of Ipomoea aquatica Forsk. in Traditional Medicine and Pharmacology
Introduction: Ipomoea aquatica Forssk. (water spinach) is widely employed in Ayurvedic and Southeast Asian traditional medicine for the management of jaundice, hepatic disorders, diabetes, febrile conditions, and neuropsychological symptoms. Its high nutritional value and range of active compounds make it a promising candidate for both food and medicine. This study aims to concisely delineate the traditional uses, phytochemical components, and pharmacological characteristics of I. aquatica, integrating classical knowledge with contemporary biomedical research. Method: A systematic literature review was performed throughout PubMed, Scopus, ScienceDirect, and Google Scholar for articles published from the creation of the databases up to June 2025. The literature search employed some important keywords, including "Ipomoea aquatica," "phytochemistry," "ethnomedicine," "pharmacology," "toxicology," and "nutraceuticals," and the selected literature includes peer-reviewed articles, ethnobotanical studies, and experimental research. The data were categorized into five key sections: traditional uses, phytochemical components, pharmacological effects, toxicological results, and nutraceutical importance. Result: The phytochemical profile of I. aquatica reveals a wide range of chemicals including flavonoids like quercetin and rhamnetin, phenolics like ellagic acid and salicylic acid glucoside, carotenoids, and alkaloids. These compounds have been shown to possess antioxidant activity (with an IC50 as low as 4.4 μg/mL), hepatoprotective effects (in thioacetamide- and CClℵ- induced models), antihyperglycemic activity (through α-glucosidase inhibition), antiinflammatory properties, neuroprotective effects, antibacterial activity, and cytotoxic activity. The plant is abundant in essential nutrients, such as iron, calcium, vitamins, fiber, and protein. Discussion: Current evidence substantiates several conventional assertions, but the majority of data originates from in vitro or animal research. Differences in extraction techniques, plant chemotypes, and experimental paradigms hinder comparison among studies. Clinical validation is predominantly lacking. Conclusion: I. aquatica demonstrates significant ethnomedicinal relevance and substantial pharmacological potential, supported by extensive phytochemical and laboratory data. The nutritional profile highlights its importance as a functional food. Extensive clinical and mechanistic research is essential to transform its traditional application into evidence-based therapeutic interventions.
- 9 September 2026
- Published by Bentham Science Publishers Ltd. in Current Functional Foods
- Vol. 04, 1-17
A Narrative Review of Ipomoea aquatica Forsk. in Traditional Medicine and Pharmacology
Introduction: Ipomoea aquatica Forssk. (water spinach) is widely employed in Ayurvedic and Southeast Asian traditional medicine for the management of jaundice, hepatic disorders, diabetes, febrile conditions, and neuropsychological symptoms. Its high nutritional value and range of active compounds make it a promising candidate for both food and medicine. This study aims to concisely delineate the traditional uses, phytochemical components, and pharmacological characteristics of I. aquatica, integrating classical knowledge with contemporary biomedical research. Method: A systematic literature review was performed throughout PubMed, Scopus, ScienceDirect, and Google Scholar for articles published from the creation of the databases up to June 2025. The literature search employed some important keywords, including "Ipomoea aquatica," "phytochemistry," "ethnomedicine," "pharmacology," "toxicology," and "nutraceuticals," and the selected literature includes peer-reviewed articles, ethnobotanical studies, and experimental research. The data were categorized into five key sections: traditional uses, phytochemical components, pharmacological effects, toxicological results, and nutraceutical importance. Result: The phytochemical profile of I. aquatica reveals a wide range of chemicals including flavonoids like quercetin and rhamnetin, phenolics like ellagic acid and salicylic acid glucoside, carotenoids, and alkaloids. These compounds have been shown to possess antioxidant activity (with an IC50 as low as 4.4 μg/mL), hepatoprotective effects (in thioacetamide- and CClℵ- induced models), antihyperglycemic activity (through α-glucosidase inhibition), antiinflammatory properties, neuroprotective effects, antibacterial activity, and cytotoxic activity. The plant is abundant in essential nutrients, such as iron, calcium, vitamins, fiber, and protein. Discussion: Current evidence substantiates several conventional assertions, but the majority of data originates from in vitro or animal research. Differences in extraction techniques, plant chemotypes, and experimental paradigms hinder comparison among studies. Clinical validation is predominantly lacking. Conclusion: I. aquatica demonstrates significant ethnomedicinal relevance and substantial pharmacological potential, supported by extensive phytochemical and laboratory data. The nutritional profile highlights its importance as a functional food. Extensive clinical and mechanistic research is essential to transform its traditional application into evidence-based therapeutic interventions.
- Open Access
- 1 March 2023
- Published by Acta Scientific Publications Pvt. Ltd. in Acta Scientific Medical Sciences
- Vol. 7 (3) , 05-19
A Comprehensive Survey Report on Women Health Care Problems at the age Group of 18-30 Years
- 1 March 2023
- Published by Acta Scientific Publications Pvt. Ltd. in Acta Scientific Medical Sciences
- Vol. 7 (3) , 05-19
Open AccessA Comprehensive Survey Report on Women Health Care Problems at the age Group of 18-30 Years
- 4 February 2023
- Published by Sciencedomain International
- p. 55-74
Innovative Pharmaceutical Excipient and Their Evaluation: A Study on Okra Fruit
Green pharmaceuticals are demanding popularity globally. In many pharmaceutical formulations, plant-based gums and mucilages are the major ingredients because of their bioavailability, widespread accessibility, non-toxicity, and reasonable prices. The main objective of this study was to isolate and analysis of the mucilage to exhibit the fundamental characteristics and quality control parameters of okra mucilage, determination of some bioactive compounds through the application of high-performance liquid chromatography to furnish insight into its potential use in the World of Pharma and World of Nutrition.
- 4 February 2023
- Published by Sciencedomain International
- p. 55-74
Innovative Pharmaceutical Excipient and Their Evaluation: A Study on Okra Fruit
Green pharmaceuticals are demanding popularity globally. In many pharmaceutical formulations, plant-based gums and mucilages are the major ingredients because of their bioavailability, widespread accessibility, non-toxicity, and reasonable prices. The main objective of this study was to isolate and analysis of the mucilage to exhibit the fundamental characteristics and quality control parameters of okra mucilage, determination of some bioactive compounds through the application of high-performance liquid chromatography to furnish insight into its potential use in the World of Pharma and World of Nutrition.
- Open Access
- 9 August 2016
- Published by Wiley in Scientifica
- Vol. 2016, 1-9
Formulation and Pharmacokinetic Evaluation of Microcapsules Containing Pravastatin Sodium Using Rats
Pravastatin Sodium has a cholesterol lowering agent. It has shorter half-life and undergoes first-pass metabolism. Frequent dose is required in case of conventional dosage form. The purpose of the study is to formulate and evaluate microcapsules containing Pravastatin Sodium by complex with cholestyramine resins coated with Eudragit RLPO and Eudragit RSPO polymers for achieving control release. Complexation of drug on resin was carried out by batch method. Microencapsulation was carried out by nonaqueous solvent evaporation method. Pharmacokinetic studies were done by using rats. The intermediate stability studies were carried out on the most satisfactory formulations. FTIR, X-ray diffraction, and DSC spectra of drug, drug-resinates, and polymers revealed no chemical interaction. The % DEE and % yield were observed for formulations of f1 to f7 that were varied from 97.1 ± 0.8 to 98.9 ± 0.5% and 95.0 ± 3.25 to 98.8 ± 7.1%, respectively. Most satisfactory formulation, f6, showed drug release up to 72.6%. No changes in % DEE and % CDR were observed after stability studies. Microcapsules of f6 formulation achieved best performance regardingin vitrodrug release and from pharmacokinetic evaluation mean residence time was found to be 6.3 h, thus indicated, Pravastatin Sodium microcapsules were released and absorbed slowly over a prolonged period of time.
- 9 August 2016
- Published by Wiley in Scientifica
- Vol. 2016, 1-9
Open AccessFormulation and Pharmacokinetic Evaluation of Microcapsules Containing Pravastatin Sodium Using Rats
Pravastatin Sodium has a cholesterol lowering agent. It has shorter half-life and undergoes first-pass metabolism. Frequent dose is required in case of conventional dosage form. The purpose of the study is to formulate and evaluate microcapsules containing Pravastatin Sodium by complex with cholestyramine resins coated with Eudragit RLPO and Eudragit RSPO polymers for achieving control release. Complexation of drug on resin was carried out by batch method. Microencapsulation was carried out by nonaqueous solvent evaporation method. Pharmacokinetic studies were done by using rats. The intermediate stability studies were carried out on the most satisfactory formulations. FTIR, X-ray diffraction, and DSC spectra of drug, drug-resinates, and polymers revealed no chemical interaction. The % DEE and % yield were observed for formulations of f1 to f7 that were varied from 97.1 ± 0.8 to 98.9 ± 0.5% and 95.0 ± 3.25 to 98.8 ± 7.1%, respectively. Most satisfactory formulation, f6, showed drug release up to 72.6%. No changes in % DEE and % CDR were observed after stability studies. Microcapsules of f6 formulation achieved best performance regardingin vitrodrug release and from pharmacokinetic evaluation mean residence time was found to be 6.3 h, thus indicated, Pravastatin Sodium microcapsules were released and absorbed slowly over a prolonged period of time.
- 9 October 2013
- Published by Taylor & Francis in Drug Delivery
- Vol. 21 (3) , 173-184
Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery
Novel LNCs (lipid nanocrystals) were developed with an aim to improve the solubility, stability and targeting efficiency of the model drug glibenclamide (GLB). PEG 20000, Tween 80 and soybean lecithin were used as polymer, surfactant and complexing agent, respectively. GLB nanocrystals (NCs) were prepared by precipitation process and complexed using hot and cold melt technique. The LNCs were evaluated by drug loading, saturation solubility (SL), optical clarity, in vitro dissolution, solid state characterization, in vivo and stability analysis. LNCs exhibited a threefold increase in SL and a higher dissolution rate than GLB. The percentage dissolution efficiency was found to decrease with increase in PEG 20000. The average particle size was in the range of 155–842 nm and zeta potential values tend to increase after complexation. X-ray powder diffractometry and differential scanning calorimetry results proved the crystallinity prevailed in the samples. Spherical shaped particles (In vivo study findings showed a decrease in drug concentration to pancreas in male Wistar rats. It can be concluded that LNCs are could offer enhanced solubility, dissolution rate and stability for poorly water soluble drugs. The targeting efficiency of LNCs was decreased and further membrane permeability studies ought to be carried out.
- 9 October 2013
- Published by Taylor & Francis in Drug Delivery
- Vol. 21 (3) , 173-184
Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery
Novel LNCs (lipid nanocrystals) were developed with an aim to improve the solubility, stability and targeting efficiency of the model drug glibenclamide (GLB). PEG 20000, Tween 80 and soybean lecithin were used as polymer, surfactant and complexing agent, respectively. GLB nanocrystals (NCs) were prepared by precipitation process and complexed using hot and cold melt technique. The LNCs were evaluated by drug loading, saturation solubility (SL), optical clarity, in vitro dissolution, solid state characterization, in vivo and stability analysis. LNCs exhibited a threefold increase in SL and a higher dissolution rate than GLB. The percentage dissolution efficiency was found to decrease with increase in PEG 20000. The average particle size was in the range of 155–842 nm and zeta potential values tend to increase after complexation. X-ray powder diffractometry and differential scanning calorimetry results proved the crystallinity prevailed in the samples. Spherical shaped particles (In vivo study findings showed a decrease in drug concentration to pancreas in male Wistar rats. It can be concluded that LNCs are could offer enhanced solubility, dissolution rate and stability for poorly water soluble drugs. The targeting efficiency of LNCs was decreased and further membrane permeability studies ought to be carried out.
- 1 March 2012
- Published by Bentham Science Publishers Ltd. in Current Drug Delivery
- Vol. 9 (2) , 197-204
Sustained Ocular Delivery of Brimonidine Tartrate Using Ion Activated In Situ Gelling System
The poor bioavailability and therapeutic response exhibited by conventional eye drops due to rapid precorneal elimination of the drug may be overcome by the use of an in situ gelling systems that are instilled as drops into the eye and undergo a sol-to-gel transition in the cul-de-sac which improves patient compliance as the dosage regimen is one drop of the dosage form twice a day. The loss of drug overcomes due to the immediate gel formation between the eye membrane and the drug being entrapped simultaneously in sol – gel transition in the cul de sac. The present work describes the formulation and evaluation of an ophthalmic delivery system of an antiglaucomal agent, brimonidine tartrate based on the concept of ion-activated in situ gelation. Gelrite was used as the gelling agent, which gels in the presence of mono or divalent cations present in the lacrimal fluid. The formulations were evaluated for clarity, pH measurement, gelling capacity, drug content estimation, rheological study, in-vitro diffusion study, antibacterial activity, isotonicity testing, eye irritation testing. In the developed formulations Gelrite Brimonidine-3 (GB3) exhibited sustained release of drug from formulation over a period of 8hrs thus increasing residence time of the drug, non-irritating with no ocular damage or abnormal clinical signs to the cornea, iris or conjunctiva, stable and sterile. These results demonstrate that the developed system is an alternative to conventional ophthalmic drops, with better patient compliance, and is industrially oriented and economical.
- 1 March 2012
- Published by Bentham Science Publishers Ltd. in Current Drug Delivery
- Vol. 9 (2) , 197-204
Sustained Ocular Delivery of Brimonidine Tartrate Using Ion Activated In Situ Gelling System
The poor bioavailability and therapeutic response exhibited by conventional eye drops due to rapid precorneal elimination of the drug may be overcome by the use of an in situ gelling systems that are instilled as drops into the eye and undergo a sol-to-gel transition in the cul-de-sac which improves patient compliance as the dosage regimen is one drop of the dosage form twice a day. The loss of drug overcomes due to the immediate gel formation between the eye membrane and the drug being entrapped simultaneously in sol – gel transition in the cul de sac. The present work describes the formulation and evaluation of an ophthalmic delivery system of an antiglaucomal agent, brimonidine tartrate based on the concept of ion-activated in situ gelation. Gelrite was used as the gelling agent, which gels in the presence of mono or divalent cations present in the lacrimal fluid. The formulations were evaluated for clarity, pH measurement, gelling capacity, drug content estimation, rheological study, in-vitro diffusion study, antibacterial activity, isotonicity testing, eye irritation testing. In the developed formulations Gelrite Brimonidine-3 (GB3) exhibited sustained release of drug from formulation over a period of 8hrs thus increasing residence time of the drug, non-irritating with no ocular damage or abnormal clinical signs to the cornea, iris or conjunctiva, stable and sterile. These results demonstrate that the developed system is an alternative to conventional ophthalmic drops, with better patient compliance, and is industrially oriented and economical.